Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.75p +1.44% 53.00p 52.00p 54.00p 53.00p 52.25p 52.25p 104,759 12:01:35
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Support Services 0.4 -5.4 -8.6 - 39.65

Angle Share Discussion Threads

Showing 46176 to 46200 of 46200 messages
Chat Pages: 1848  1847  1846  1845  1844  1843  1842  1841  1840  1839  1838  1837  Older
DateSubjectAuthorDiscuss
25/7/2017
19:07
Oiht, would be nice. I think they are out on Thursday though.
stevelauren23
25/7/2017
19:03
I've got a prediction for Friday. "Research sales have forged ahead above and beyond all expectations and the company are pleased to announce a maiden divided of 1p" ;-)
oiht
25/7/2017
16:13
Q4 last year, a share that I have been watching closely, epic wand, £1.40, now £6.70, personally I can see a lot of similarities with Angle....Hence why I am staying fully loaded........
willfy
25/7/2017
13:25
The only two other CTC co's who have some kind of plan re FDA approval, that I have seen, are Vortex and Celsee, the others just talk about it vaguely sometimes, despite running various clinical trials akin to the Euro one AGL have. Vortex talk about FDA Approval in 2019 with I think, a second generation machine, Celsee, despite have similar tech to AGL and the ability to process several samples at once, seem to want to demonstrate equivalence to Cellsearch. Like AGL Celsee also have people on board who oversaw the original Cellsearch Approval. In retrospect, if AGL had gone down the equivalence to Cellsearch route they would probably have FDA Approval by now, but only for Cellsearch style apps. If AGL get FDA approval other co's will then have a somewhat easier route I think, by opting to demonstrate equivalence to Parsortix in performance terms, rather than doing too much trailblazing.
banshee
25/7/2017
13:24
The validation process for Parsortix and other tools must depend on whether they are trying to sell it as a clincal cancer test for a specific cancer, or a very useful too with unique properties. IMO if rival tool manufacturers prove the function capability of their tool, and then push commercialisation and links with those companies using their tool, they could build up a good business whilst Parsortix is still struggling to get validation for individual clinical uses. Rival companies could build up good cash flow whilst Parsortix has delusions of grandeur!
tidcombe
25/7/2017
10:22
Does anyone here know for sure that any competition DOESNT have to go through the same lengthy and rigorous validation process as well. If it does then that is some significant barrier to entry in what we believe is a very substantial market. How far progressed are rival technologies down the path of validation in parsortix'svarious markets?
bagpuss67
25/7/2017
09:39
Yes Willfy and Life - both good points. One would have thought that the share price would have been kept higher as a fund raising at this level would not be good for anyone. I can only hope that they have a cunning plan and some good news up their sleeves.
semper vigilans
25/7/2017
09:35
Hoping for clarity on Thursday regarding cash burn, revenue, and do they foresee any more fund raising
willfy
25/7/2017
08:54
Well said wilfy.
bagpuss67
25/7/2017
08:11
The funding requirements are a problem with share price this low. Last fund raise was at 65p I think This next fund raise should be higher but unless we receive positive income results then I am concerned the 50 p level will be the strike price Problem is that causes even greater dilution ..
life guard
24/7/2017
22:31
Wilfy we all want share price to go up as I presume most of us on this board are under water including myself this been an absolute dog overlast few years.Im wainting till thursday and then its gonna be do or die
myszka21
24/7/2017
22:26
Revenues,revenues only an only gonna move this share price go sky high for time being this is a far distant word
myszka21
24/7/2017
22:18
I know you have always been a strong believer here Willfy and like us all you will be frustrated watching the share price drift down day after day. There is the situation of the cash position with perhaps another fundraise coming up in the near future. I'm not expecting much from the Prelims but l really hope the research sales are good and we are not let down there. I, like many still feel that all will come good eventually but at times the patience is wearing thin.
maxie23
24/7/2017
21:44
As frustrating as it is at the moment, now is not the time to lose faith in AN and Angle.In my humble opinion, we are potentially days, weeks or even months away from significant progress been made.If investing in stocks was easy, then half the population would be potentially very rich, as I believe we will be once this share finally takes off......
willfy
24/7/2017
17:08
What - you as well?!?
semper vigilans
24/7/2017
14:21
... and I'm awarding myself another bonus despite the share price going nowhere !
mikepompeyfan
24/7/2017
14:16
I do not think thursday gonna change anythink it be typical an story like"we are making progress etc."
myszka21
24/7/2017
13:44
Drifting till Thursday?
semper vigilans
21/7/2017
20:01
Not just any old mice but humanised mice ! hTTps://www.jax.org/jax-mice-and-services/in-vivo-pharmacology/humanized-mice
miavoce
21/7/2017
13:57
The mice thing was first mooted by AGL about 4 or 5 years back, and has been characteristically slow to arrive. The rationale, which as usual has been forgotten by people on here, was that certain "designer" lab mice can actually be very expensive and this tech might allow some of them to be "reused" rather than sacrificed, which all sounds brutal, but is, for better or worse, the reality.
banshee
21/7/2017
12:43
Whilst the revenue is important, I think we need a cure for the ongoing financing situation which seems to be holding back the share price
semper vigilans
21/7/2017
11:52
Sp itself its absolutly pathetic apart from one sharp rise episode this is share is a dog I can wait for thursday to see how he gonna say about revenue!!!!this is what we all are intrested in
myszka21
21/7/2017
11:01
Trickle down.... Reminds me of the share price :(
boris cobaka
21/7/2017
09:31
Well Parsortix is already in quite a few top notch research establishments, which, with any luck, should trickle down.
semper vigilans
21/7/2017
09:27
I'm hopeful.
oiht
Chat Pages: 1848  1847  1846  1845  1844  1843  1842  1841  1840  1839  1838  1837  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V: D:20170726 00:55:50